Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
30 Nov 2022
Historique:
received: 19 10 2022
revised: 22 11 2022
accepted: 25 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Acromegaly results from growth hormone hypersecretion, predominantly caused by a somatotroph pituitary neuroendocrine tumor (PitNET). Acromegaly-causing tumors are histologically diverse. Our aim was to determine transcriptomic profiles of various somatotroph PitNETs and to evaluate clinical implication of differential gene expression. A total of 48 tumors were subjected to RNA sequencing, while expression of selected genes was assessed in 134 tumors with qRT-PCR. Whole-transcriptome analysis revealed three transcriptomic groups of somatotroph PitNETs. They differ in expression of numerous genes including those involved in growth hormone secretion and known prognostic genes. Transcriptomic subgroups can be distinguished by determining the expression of marker genes. Analysis of the entire cohort of patients confirmed differences between molecular subtypes of tumors. Transcriptomic group 1 includes ~20% of acromegaly patients with

Identifiants

pubmed: 36497102
pii: cells11233846
doi: 10.3390/cells11233846
pmc: PMC9738119
pii:
doi:

Substances chimiques

Growth Hormone 9002-72-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Maria Sklodowska-Curie National Research Institute of Oncology
ID : SN/GW04/2020

Références

J Neuroendocrinol. 2011 Jul;23(7):641-9
pubmed: 21554434
J Clin Endocrinol Metab. 2019 May 1;104(5):1777-1787
pubmed: 30376114
J Clin Invest. 2015 Apr;125(4):1692-702
pubmed: 25774503
Endocr Pathol. 2022 Mar;33(1):6-26
pubmed: 35291028
Front Endocrinol (Lausanne). 2021 Mar 15;12:646210
pubmed: 33790868
PLoS One. 2014 Oct 21;9(10):e110543
pubmed: 25334044
Neurosurgery. 1993 Oct;33(4):610-7; discussion 617-8
pubmed: 8232800
Biomedicines. 2022 Feb 16;10(2):
pubmed: 35203668
Mol Cell Endocrinol. 2018 Mar 5;463:23-36
pubmed: 28652171
Endocrinology. 2018 Dec 1;159(12):4043-4055
pubmed: 30395240
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027913
pubmed: 34212819
Mol Cell Endocrinol. 2015 Dec 5;417:73-83
pubmed: 26391562
Endocr Pathol. 2005 Fall;16(3):187-94
pubmed: 16299401
Endocr Relat Cancer. 2020 Jun;27(6):375-389
pubmed: 32302973
J Clin Med. 2019 Nov 13;8(11):
pubmed: 31766255
J Clin Med. 2021 Feb 03;10(4):
pubmed: 33546126
Endocrinology. 2013 Dec;154(12):4715-25
pubmed: 24169548
Diabetes. 2012 Jan;61(1):40-8
pubmed: 22043004
Braz J Med Biol Res. 2017 Dec 11;51(2):e6808
pubmed: 29267504
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Pituitary. 2021 Apr;24(2):192-206
pubmed: 33074402
Eur J Endocrinol. 2021 May 10;184(6):R261-R268
pubmed: 33830942
Hormones (Athens). 2022 Mar;21(1):1-14
pubmed: 35061210
Curr Med Chem. 2021;28(13):2565-2576
pubmed: 32538716
Rev Endocr Metab Disord. 2020 Mar;21(1):165-183
pubmed: 31933128
Genome Biol. 2014;15(12):550
pubmed: 25516281
Eur J Endocrinol. 2013 Mar 15;168(4):491-9
pubmed: 23288882
Eur J Endocrinol. 2016 Feb;174(2):241-50
pubmed: 26586796
Horm Res. 2009 Apr;71 Suppl 2:95-100
pubmed: 19407505
Front Endocrinol (Lausanne). 2021 Mar 11;12:636403
pubmed: 33776931
Bioinformatics. 2013 Jul 15;29(14):1830-1
pubmed: 23740750
Endokrynol Pol. 2019;70(1):2-18
pubmed: 30843181
Pituitary. 2015 Dec;18(6):861-7
pubmed: 26115707
World Neurosurg. 2021 Sep;153:e20-e27
pubmed: 34087455
Cancer Cell. 2020 Jan 13;37(1):123-134.e5
pubmed: 31883967
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Sci Rep. 2019 Feb 4;9(1):1122
pubmed: 30718563
J Neuroendocrinol. 2016 Feb;28(2):12352
pubmed: 26686489
Eur J Endocrinol. 2017 May;176(5):543-553
pubmed: 28179449
N Engl J Med. 2006 Dec 14;355(24):2558-73
pubmed: 17167139
Eur J Endocrinol. 2016 May;174(5):651-62
pubmed: 26888629
Endocr Relat Cancer. 2017 Mar;24(3):C1-C4
pubmed: 28122798
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):193-202
pubmed: 24373949
Clin Endocrinol (Oxf). 2021 May;94(5):811-819
pubmed: 32978826

Auteurs

Julia Rymuza (J)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Paulina Kober (P)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Natalia Rusetska (N)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Beata J Mossakowska (BJ)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Maria Maksymowicz (M)

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Aleksandra Nyc (A)

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Szymon Baluszek (S)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Grzegorz Zieliński (G)

Department of Neurosurgery, Military Institute of Medicine, 04-141 Warsaw, Poland.

Jacek Kunicki (J)

Department of Neurosurgery, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Mateusz Bujko (M)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH